Zoetis

Zoetis The world’s leading animal health company, driven by a singular purpose: to nurture our world and humankind by advancing care for animals. Thank you.

With a legacy of nearly 75 years, Zoetis continues to pioneer ways to predict, prevent, detect, and treat animal illness, supporting veterinarians, livestock producers, and pet owners in over 100 countries. We integrate deep scientific expertise, data-driven R&D, advanced manufacturing, and commercial excellence to deliver meaningful innovation across medicines, vaccines, diagnostics, biopharmaceu

ticals, and digital solutions. Guided by our vision to be the most trusted and valued animal health company, Zoetis is committed to setting new standards for the future of animal care through innovation, customer obsession, and purpose-driven colleagues. To learn more, visit Zoetis.com. Zoetis Community Guidelines

This community is intended to be a place for veterinarian healthcare teams, livestock farmers and pet owners to learn more about how Zoetis is advancing care for animals. We aspire to create a genuine and supportive community, and we welcome productive, helpful, informative contributions to the page. To that end, and to ensure respectful and professional space, there are some guidelines to which posts and comments on this page must adhere. Please note that if your post references a side effect related to any Zoetis product, including, without limitation, those listed below, we may contact you for more information.

• Apoquel® (oclacitinib tablet)
• Cytopoint®
• Sileo® (dexmedetomidine oromucosal gel)
• Revolution® (selamectin)
• Revolution®Plus (selamectin and sarolaner topical solution)
• Simparica® (sarolaner) Chewables
• Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets)
• ProHeart®6 (moxidectin)
• ProHeart®12 (moxidectin)
• Convenia® (cefovecin sodium)
• Rimadyl® (carprofen)
• Cerenia® (maropitant citrate)
• Solensia® (frunevetmab injection)
• Librela®(bedinvetmab injection)

To monitor the safety of Zoetis products, we advise you to contact our Veterinary Medical Information and Product Support Team; in the U.S. at https://www.zoetisus.com/product-support/vmips/contact-vmips OR call 1-888-963-8471. Our Support Team is available Monday through Friday 9am to 6:30pm ET. For any international reporting please use this link: https://www.zoetis.com/customer-care -in-touch. We reserve the right to remove or moderate any content that violates these Community Guidelines or Facebook’s Terms and Community Standards. Please refrain from posting content that includes:

• Medical advice (including diagnosis/treatment instructions) or medical misinformation; please share personal experiences without directing others what to do medically
• Profanity/vulgarity or obscene content
• Discriminatory, derogatory, or hateful content (including hate speech)
• Disinformation (fabricated or manipulated information designed to deceive or cause harm)
• Politics or religious commentary (unless explicitly invited by a moderator/admin post)
• Personal attacks, harassment, or threats
• Promotion of illegal activity
• Copyright or trademark infringement
• Self-promotion or advertising (including solicitations)
• Graphic or disturbing imagery
• Images/flyers/videos/links with no context or commentary (unless requested in the original post)
• Spam (repeatedly posting the same/similar comment on a single post and/or the same individual posting the same/similar comment across multiple Zoetis posts)

Repeated or severe violations may result in content removal and/or the user being muted, removed, or blocked. We are committed to responding to our community messages in a timely manner. Responses may not be immediate. Our regular business hours are Monday through Friday 9 AM to 5 PM (ET). If a message is sent or a comment is made outside of regular business hours, or on weekends or holidays, please expect a delay in response. Zoetis does not endorse and is not responsible for information and opinions shared by community members. The information contained in the community is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. Testimonials represent individual experience only and the experiences and opinions of community members may be unique to the speaker. Terms of Use: https://www.zoetis.com/terms-of-use.

At Zoetis, our commitment to animal health is closely connected to the health of the environments and communities we sha...
04/22/2026

At Zoetis, our commitment to animal health is closely connected to the health of the environments and communities we share. On this Earth Day, we’re recognizing a few examples of colleagues around the world who are taking action to help protect and restore local ecosystems.

In New Jersey, colleagues came together for a coastal cleanup—collecting litter and helping restore a shoreline that both people and wildlife depend on. In Mumbai, India, colleagues spent time in a nature reserve clearing waste from forest trails and supporting conservation efforts by building natural structures to help manage water flow, recharge groundwater, and sustain surrounding vegetation.

These hands-on efforts, while local in impact, contribute to a broader commitment to a healthier, more sustainable future for animals, people, and the planet.

We’re excited to share that Vetscan OptiCell™ will be the first and only point‑of‑care hematology analyzer to offer Cell...
04/21/2026

We’re excited to share that Vetscan OptiCell™ will be the first and only point‑of‑care hematology analyzer to offer Cellular Hemoglobin Concentration Mean (CHCM). Previously available only in reference labs, this direct measurement of the average hemoglobin concentration within individual red blood cells delivers greater accuracy than traditional calculated values—especially in complex cases.

Building on OptiCell’s AI-powered, cartridge-based platform that already provides complete blood count (CBC) results in-clinic, we’re expanding capabilities in 2026 with two new parameters, bringing the total to 24. Alongside CHCM, Plateletcrit (PCT) adds insight into platelet volume and health, helping clinicians more effectively detect changes in production or destruction.

Together, these enhancements strengthen OptiCell’s ability to deliver fast, actionable results at the point of care—supporting veterinary teams in making informed decisions and improving patient outcomes.

Read more: https://news.zoetis.com/press-releases/press-release-details/2026/Zoetis-Expands-Vetscan-OptiCell-Capabilities-Becoming-the-First-and-Only-Point-of-Care-Hematology-Analyzer-to-Offer-Cellular-Hemoglobin-Concentration-Mean-2026-0Y06C02UfA/default.aspx?utm_source=facebook&utm_medium=social&utm_campaign=vetscan_opticell_expanding_capabilities&utm_content=graphic

04/14/2026

We’re celebrating five years of the Zoetis Foundation’s work supporting those who care for animals.

The Foundation has distributed $35 million in grant funding from 2021 through the end of 2025 to advance opportunities for veterinary professionals and livestock farmers in addition to supporting humanitarian aid and a matching gifts program. Together with incredible grantees worldwide, the Foundation is making a difference by investing in people who share their time, skills, and care for animals every day.

Learn more about the Foundation’s impact: https://www.zoetis.com/news-and-insights/featured-stories/caring-for-those-who-care-for-animals-the-zoetis-foundations-first-five-years?utm_source=facebook&utm_medium=social&utm_campaign=vid_impact_copy&utm_content=video

04/13/2026

Currently, veterinary healthcare teams can only provide palliative care for certain chronic diseases like kidney disease.

Our scientists want to change that.

They’ve spent more than a decade researching and developing monoclonal antibodies (mAbs) with the goal of expanding the therapeutic options available to treat chronic diseases in pets.

Learn more: https://www.zoetis.com/news-and-insights/blog/mabs-the-rising-wave-of-innovations-in-veterinary-medicine?utm_source=facebook&utm_medium=social&utm_campaign=mabs_blog&utm_content=vid_mabs-what_illust_chronic-copy_precision-hl

03/30/2026

Change takes shape through people.

Through local organizations working in their communities. Through the veterinarians, farmers, and students whose dedication helps animals thrive and supports the livelihoods built around them.

We’re honoring 5 years of the Zoetis Foundation and the many hands behind its impact. We’re thankful for our grantees around the world for their leadership, commitment, and work—today, and for the years ahead.

03/24/2026

Today, on National Agriculture Day, we honor the women who power our farms, ranches, and agricultural communities. For generations, they’ve led with resilience—through unpredictable weather, shifting markets, and evolving disease risks. At Zoetis, we remain dedicated to the women driving the industry forward, delivering innovations and services that help safeguard animal health and strengthen productivity.

03/23/2026

What are monoclonal antibodies (mAbs) and how do they work?

Scientists engineer mAbs to be species specific. They are designed to mimic a pet’s naturally occurring antibodies and are intended to provide highly targeted treatment.

Learn how our scientists aim to address unmet needs in animal health with these innovative therapies. https://brnw.ch/21x0Yvg

03/20/2026

On World Parasite Awareness Day, we’re highlighting the importance of proactive parasite prevention to help reduce discomfort, illness, and even life-threatening disease. With evolving environmental conditions, parasite risk can shift across borders—reinforcing the need for awareness and veterinary guidance on the most appropriate preventive care.

We’re committed to supporting veterinarians and the broader animal health community through tools and education that help protect pets and the people who care for them.

03/18/2026

Veterinary professionals and livestock farmers don’t just care for animals, they sustain communities, and their impact reaches far beyond the clinic and farm.

Five years ago, the Zoetis Foundation was established to support the people who care for animals to ensure their essential work continues. Acknowledging the pressures they face, the Foundation invests in initiatives that advance opportunities for veterinary professionals and livestock farmers.

We’re proud of the progress made so far and will continue to deepen the Foundation’s impact around the world.

Learn more: https://www.zoetis.com/news-and-insights/featured-stories/caring-for-those-who-care-for-animals-the-zoetis-foundations-first-five-years?utm_source=facebook&utm_medium=social&utm_campaign=foundation_5year_impact&utm_content=vid_care_copy

03/11/2026

What goes into making monoclonal antibodies for pets? It’s no easy task.

Our meticulous approach can be captured in four steps, but there’s so much more that goes on behind the scenes to develop innovative solutions.

Watch the video to peek into the process and learn more here: https://www.zoetis.com/news-and-insights/blog/mabs-the-rising-wave-of-innovations-in-veterinary-medicine?utm_source=facebook&utm_medium=social&utm_campaign=mabs_blog&utm_content=vid_mabs-make_mabs-make-copy_unmet-hl

03/10/2026

We appreciated the opportunity to join industry leaders at the Animal Health Nutrition, Technology and Innovation Summit in London for timely conversations on the future of animal health. As our industry evolves, continued collaboration across the animal health ecosystem will be essential to advancing more predictive, preventive care and delivering lasting impact for animals and the people who depend on them.

Address

Parsippany, NJ

Website

Alerts

Be the first to know and let us send you an email when Zoetis posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Zoetis:

Shortcuts

Share

Category